Quarterly report pursuant to Section 13 or 15(d)

Business and Summary of Significant Accounting Policies (Details)

v3.23.1
Business and Summary of Significant Accounting Policies (Details)
3 Months Ended 12 Months Ended
Mar. 20, 2023
USD ($)
Feb. 13, 2023
$ / shares
Jan. 24, 2023
director
Jan. 18, 2023
$ / shares
Dec. 19, 2022
Jun. 23, 2022
$ / shares
Mar. 31, 2023
USD ($)
customer
segment
shares
Mar. 31, 2022
USD ($)
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Business and Summary of Significant Accounting Policies                    
Allowance for doubtful accounts             $ 0   $ 0  
Deferred offering costs             $ 0   206,000,000  
Number of operating segments     1       1      
Remaining performance obligation             false      
Advertising costs             $ 155,000,000 $ 171,000,000    
Stockholders' equity             $ 7,763,000 $ 12,986,000 (1,996,000) [1] $ 16,377,000
Number of customers | customer             1      
Warranty period of company products             1 year      
Extension period to regain compliance with Minimum Bid Price Requirement         180 days          
Closing bid price | $ / shares   $ 1.00   $ 0.10   $ 1.00        
Consecutive business days to maintain bid price requirement   10 days   10 days            
Reverse stock split     0.01       0.01      
Stockholders' Equity Requirement $ 2,500,000               $ 2,500,000  
Stockholders' equity (deficit) $ 1,996,000                  
Warrant                    
Business and Summary of Significant Accounting Policies                    
Antidilutive securities excluded from computation of earnings per share, amount | shares             2,680,998 44,744    
Restricted stock                    
Business and Summary of Significant Accounting Policies                    
Antidilutive securities excluded from computation of earnings per share, amount | shares             14,064 15,688    
Restricted stock units                    
Business and Summary of Significant Accounting Policies                    
Antidilutive securities excluded from computation of earnings per share, amount | shares             2,778 2,971    
Convertible Preferred Stock                    
Business and Summary of Significant Accounting Policies                    
Antidilutive securities excluded from computation of earnings per share, amount | shares             5,847 4,274    
Accounts Receivable | Customer Concentration Risk                    
Business and Summary of Significant Accounting Policies                    
Number of customers | customer             2      
Accounts Receivable | Customer Concentration Risk | Customer 1                    
Business and Summary of Significant Accounting Policies                    
Concentration risk, percentage             86.00%   62.00%  
Accounts Receivable | Customer Concentration Risk | Customer 2                    
Business and Summary of Significant Accounting Policies                    
Concentration risk, percentage                 12.00%  
Sales Revenue, Net | Customer Concentration Risk                    
Business and Summary of Significant Accounting Policies                    
Number of customers | customer             3      
Sales Revenue, Net | Customer Concentration Risk | Customer 1                    
Business and Summary of Significant Accounting Policies                    
Concentration risk, percentage             45.00% 36.00%    
Sales Revenue, Net | Customer Concentration Risk | Customer 2                    
Business and Summary of Significant Accounting Policies                    
Concentration risk, percentage             10.00% 25.00%    
Sales Revenue, Net | Customer Concentration Risk | Customer 3                    
Business and Summary of Significant Accounting Policies                    
Concentration risk, percentage               16.00%    
[1] The condensed consolidated balance sheet as of December 31, 2022 was derived from the audited consolidated balance sheet as of that date.